Vivos Therapeutics, Inc. (VVOS) NASDAQ
1.30
-0.04(-2.99%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.30
-0.04(-2.99%)
Currency In USD
| Market Cap | 21.54M |
| Enterprise Value | 16.79M |
| P/E Ratio | -0.83 |
| PEG Ratio | 0.17 |
| Price/Sales Ratio | 0.44 |
| Price/Book Ratio | 5.63 |
| Enterprise/Revenue | 0.99 |
| Enterprise/EBITDA | -1.07 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -0.99 |
| Operating Margin | -0.91 |
| Return On Assets | -0.67 |
| Return On Equity | -3.51 |
| Revenue | 15.03M |
| Revenue/Share | 1.58 |
| Gross Profit | 9.02M |
| EBITDA | -10.56M |
| Net Income | -11.14M |
| Diluted EPS | -2.22 |
| Total Cash | 3.09M |
| Total Cash/Share | 0.28 |
| Total Debt | 12.5M |
| Total Debt/Equity | 4.94 |
| Current Ratio | 0.78 |
| Book Value Per Share | 0.23 |
| 52-Week Change | -58.86 |
| 52-Week High | 7.95 |
| 52-Week Low | 1.26 |
| Moving Average 50 Days | 1.74 |
| Moving Average 200 Days | 2.96 |
| Average Volume | 123,601 |
| Shares Outstanding | 5.89M |
| % Held by Institutions | 6 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | October 27, 2023 |